Who is sponsoring NCT04082819?

NCT04082819 is sponsored by SE Health.

What condition does NCT04082819 study?

NCT04082819 studies Low Blood Pressure, Blood Pressure, High Blood Pressure, Hypertension, Hypotension.

What drugs are being tested in NCT04082819?

Interventions: Contec CMS50EW, Sphygmomanometer.

What is the status of NCT04082819?

NCT04082819 is currently COMPLETED.

Last reviewed 2020-04-01 · How we verify

MediBeat - HeartBeat Observation Trial

NCT04082819 NA COMPLETED Results posted

The goal of the study was to compare the current gold standard blood pressure instrument (a mercury-filled sphygmomanometer with cuff and stethoscope) with the new experimental algorithm developed by HeartBeat Technologies Ltd. To that end, participants were recruited from Markham, Ontario and participated in a series of alternating blood pressure measurements over a period of 45 minutes. Comparisons were made between manual measurements and device measurements to determine the quality of the device readings. Measurements were taken by trained nurses and staff were consistent across the study duration.

Details

Lead sponsor	SE Health
Phase	NA
Status	COMPLETED
Enrolment	94
Start date	Fri Oct 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Low Blood Pressure
Blood Pressure
High Blood Pressure
Hypertension
Hypotension

Interventions

Contec CMS50EW
Sphygmomanometer

Countries

Canada